Therma Bright Files Application to the OTCQB and DTC Clearing
Toronto, Ontario--(Newsfile Corp. - July 29, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen...
Technology, Biotechnology, Health
2021-07-29 7:53 AM EDT | Therma Bright Inc.
Therma Bright Awaits FDA-EUA Approval From Over 260 AcuVid(TM) Clinical Study Test Results
Toronto, Ontario--(Newsfile Corp. - July 22, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen...
Technology, Biotechnology, Health
2021-07-22 9:24 AM EDT | Therma Bright Inc.
Therma Bright's AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Successfully Detects the COVID-19 Delta Variant Strain
Toronto, Ontario--(Newsfile Corp. - July 8, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen...
Technology, Biotechnology, Health
2021-07-08 7:00 AM EDT | Therma Bright Inc.
Therma Bright Secures US Distributor 'DME Authority' for Its Patented Venowave Lightweight Deep Vein Thrombosis (DVT) Device, Just as US Healthcare Providers Deal with Device Shortages
Toronto, Ontario--(Newsfile Corp. - June 28, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen...
Technology, Biotechnology, Health
2021-06-28 8:00 AM EDT | Therma Bright Inc.
Therma Bright to Test AcuVid(TM) on the Highly Contagious COVID-19 Delta Variant, Company Completes Brazilian Clinical Study for Final FDA EUA Submission
Toronto, Ontario--(Newsfile Corp. - June 24, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen...
Technology, Biotechnology, Health
2021-06-24 7:00 AM EDT | Therma Bright Inc.
Therma Bright Reports Performance of Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test from Brazilian Clinical Study
Toronto, Ontario--(Newsfile Corp. - June 17, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva...
Technology, Biotechnology, Health
2021-06-17 5:05 PM EDT | Therma Bright Inc.
Therma Bright Provides Update on Brazilian Clinical Study
Toronto, Ontario--(Newsfile Corp. - May 27, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen...
Technology, Biotechnology, Health
2021-05-27 7:00 AM EDT | Therma Bright Inc.
Therma Bright Secures Development and Manufacturing Partner for AcuVid(TM) COVID-19 Rapid Antigen Saliva Test
Toronto, Ontario--(Newsfile Corp. - May 21, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen...
Technology, Biotechnology, Health
2021-05-21 8:00 AM EDT | Therma Bright Inc.
Therma Bright Enters into Agreement to Distribute a 15 Minute Rapid COVID-19 Antibody Test
Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva...
Technology, Biotechnology, Health
2021-05-06 7:00 AM EDT | Therma Bright Inc.
Therma Bright Partners With Afero To Make AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Smart-Enabled
Toronto, Ontario--(Newsfile Corp. - April 28, 2021) - Afero has entered into a memorandum of understanding (MOU) agreement with Therma Bright Inc. (TSXV: THRM), the...
Technology, Biotechnology, Health
2021-04-28 10:54 AM EDT | Therma Bright Inc.
Therma Bright's AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Detects the Important SARS-CoV-2 Variants of Concern; the Brazilian P.1 and P.2 and the UK B.1.1.7 Variants
Toronto, Ontario--(Newsfile Corp. - April 22, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva...
Technology, Biotechnology, Health
2021-04-22 7:00 AM EDT | Therma Bright Inc.
Therma Bright Announces EU-CE Approval for AcuVid(TM) COVID-19 Rapid Antigen Saliva Test and Conditional Sale for 100,000 CE-only AcuVid(TM) Test Kits
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva...
Technology, Biotechnology, Health
2021-04-19 8:00 AM EDT | Therma Bright Inc.
Therma Bright Provides Update on Brazilian Performance Study of its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test
Toronto, Ontario--(Newsfile Corp. - April 13, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ Covid-19 Rapid Antigen Saliva...
Technology, Biotechnology, Health
2021-04-13 8:00 AM EDT | Therma Bright Inc.
Therma Bright Receives IRB Approval and Submits Application to Health Canada to Begin Clinical Study for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test
Toronto, Ontario--(Newsfile Corp. - March 25, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ Covid-19 Rapid Antigen Saliva...
Technology, Biotechnology, Health
2021-03-25 8:00 AM EDT | Therma Bright Inc.
Therma Bright Partners with Ridge Global to Expand Its United States and Global Reach
Toronto, Ontario--(Newsfile Corp. - March 24, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVidTM COVID-19 Rapid Antigen Saliva...
Technology, Biotechnology, Health
2021-03-24 7:00 AM EDT | Therma Bright Inc.
Therma Bright Initiates Clinical Performance Study in Brazil for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test
Toronto, Ontario--(Newsfile Corp. - March 18, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased...
Technology, Biotechnology, Health
2021-03-18 8:15 AM EDT | Therma Bright Inc.
Therma Bright Submits Application to Research Ethics Board for Approval of Clinical Trials for AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test
Toronto, Ontario--(Newsfile Corp. - March 11, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased...
Technology, Biotechnology, Health
2021-03-11 7:00 AM EST | Therma Bright Inc.
Therma Bright Enters into Clinical Trial Agreement for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test
Toronto, Ontario--(Newsfile Corp. - February 26, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased...
Technology, Biotechnology, Health
2021-02-26 9:13 AM EST | Therma Bright Inc.
Therma Bright Adds $1,171,875 to Treasury Through Exercise of Warrants and Options
Toronto, Ontario--(Newsfile Corp. - January 29, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is...
Technology, Biotechnology, Health
2021-01-29 8:42 AM EST | Therma Bright Inc.
Therma Bright Acquires 100% Control of its COVID-19 Rapid Saliva Antigen Test and Announces Proposed Name Change for the Test
Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma Bright" or the "Company"), a progressive medical device technology company announces...
Technology, Biotechnology, Health
2021-01-25 6:30 AM EST | Therma Bright Inc.
Therma Bright Reports Improved Accuracy For Its COVID-19 Rapid Saliva Antigen Test, CoviSafeTM, And Prepares For Prospective Studies
Toronto, Ontario--(Newsfile Corp. - January 18, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased...
Technology, Biotechnology, Health
2021-01-18 4:00 PM EST | Therma Bright Inc.
Therma Bright Adds Veteran Manufacturing Expert to Advisory Team to Advance its Saliva-Based Rapid Antigen Test CoviSafe(TM)
Toronto, Ontario--(Newsfile Corp. - January 15, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased...
Technology, Biotechnology, Health
2021-01-15 6:30 AM EST | Therma Bright Inc.
Therma Bright Signs IR Agreement with Barwicki Investor Relations, Adds $300,000 to Treasury Through Exercise of Warrants and Options; and Grants Options
Toronto, Ontario--(Newsfile Corp. - December 24, 2020) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, announces that...
Technology, Biotechnology, Health
2020-12-24 6:39 AM EST | Therma Bright Inc.
Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva Test, CoviSafe(TM)
Toronto, Ontario--(Newsfile Corp. - December 7, 2020) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased...
Technology, Biotechnology, Health
2020-12-07 5:07 PM EST | Therma Bright Inc.
Therma Bright Creates New Venture, Torion Biosciences to Develop its COVID-19 Rapid Antigen Test, CoviSafe(TM)
Toronto, Ontario--(Newsfile Corp. - November 4, 2020) - Therma Bright Inc. (TSXV: THRM) ("Therma Bright" or the "Company"), a progressive medical device technology company announces...
Technology, Biotechnology, Health
2020-11-04 5:00 PM EST | Therma Bright Inc.